Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M W Lawless

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cytokine|May 15, 2012
Toll-like receptor signalling in liver disease: ER stress the missing link?M W Lawless, C M Greene
Foot & Ankle International|August 16, 2001
Foot pressures during gait: a comparison of techniques for reducing pressure pointsM W Lawless, G T Reveal, R T Laughlin
Current Diabetes Reviews|August 20, 2009
Histone deacetylase inhibitors target diabetes via chromatin remodeling or as chemical chaperones?M W Lawless, K J O'Byrne, S G Gray
Clinical Anatomy (New York, N.Y.)|August 20, 2011
Correlation between patella and patellar tendon width: An anatomic studyJ M Dundon, R J Markert, M W Lawless
International Journal of Immunogenetics|March 3, 2010
Highly sensitivity adhesion molecules detection in hereditary haemochromatosis patients reveals altered expressionS Norris, M White, A K Mankan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 12, 2009
Targeting histone deacetylases for the treatment of immune, endocrine & metabolic disordersM W Lawless, S Norris, K J O'Byrne, et al.
Journal of Cellular and Molecular Medicine|January 30, 2009
Targeting histone deacetylases for the treatment of diseaseM W Lawless, S Norris, K J O'Byrne, et al.
Tissue Antigens|September 5, 2007
Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosisM W Lawless, M White, A K Mankan, et al.
The Journal of Trauma|June 1, 1997
Massive pelvis injuries treated with amputations: case reports and literature reviewM W Lawless, R T Laughlin, D G Wright, et al.
International Journal of Immunogenetics|July 23, 2008
Characterization of tumour necrosis factor-alpha genetic variants and mRNA expression in patients with severe sepsisM J O'Dwyer, A K Mankan, A W Ryan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cytokine|May 15, 2012
Toll-like receptor signalling in liver disease: ER stress the missing link?M W Lawless, C M Greene
Foot & Ankle International|August 16, 2001
Foot pressures during gait: a comparison of techniques for reducing pressure pointsM W Lawless, G T Reveal, R T Laughlin
Current Diabetes Reviews|August 20, 2009
Histone deacetylase inhibitors target diabetes via chromatin remodeling or as chemical chaperones?M W Lawless, K J O'Byrne, S G Gray
Clinical Anatomy (New York, N.Y.)|August 20, 2011
Correlation between patella and patellar tendon width: An anatomic studyJ M Dundon, R J Markert, M W Lawless
International Journal of Immunogenetics|March 3, 2010
Highly sensitivity adhesion molecules detection in hereditary haemochromatosis patients reveals altered expressionS Norris, M White, A K Mankan, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets|March 12, 2009
Targeting histone deacetylases for the treatment of immune, endocrine & metabolic disordersM W Lawless, S Norris, K J O'Byrne, et al.
Journal of Cellular and Molecular Medicine|January 30, 2009
Targeting histone deacetylases for the treatment of diseaseM W Lawless, S Norris, K J O'Byrne, et al.
Tissue Antigens|September 5, 2007
Elevated MCP-1 serum levels are associated with the H63D mutation and not the C282Y mutation in hereditary hemochromatosisM W Lawless, M White, A K Mankan, et al.
The Journal of Trauma|June 1, 1997
Massive pelvis injuries treated with amputations: case reports and literature reviewM W Lawless, R T Laughlin, D G Wright, et al.
International Journal of Immunogenetics|July 23, 2008
Characterization of tumour necrosis factor-alpha genetic variants and mRNA expression in patients with severe sepsisM J O'Dwyer, A K Mankan, A W Ryan, et al.
Pageof 2